Clinical Trial Update: BMS-247550 Plus Capecitabine in Treating Patients With Metastatic Breast Cancer [Phase 1]

View source ↗

Summary

A Phase 1 study evaluating BMS-247550 in combination with capecitabine for metastatic breast cancer; the current status of the trial is not provided.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• BMS-247550
• Capecitabine (capecitabine)

Snippet

Sponsor: R-Pharm | Conditions: Breast Cancer | Phase 1 | Status: UNKNOWN